Stock listing
Blau Farmaceutica Sa
Selected listing: BLAU3 · BMFBOVESPA · BRL · BR
Blau Farmaceutica Sa (B3:BLAU3), Health Technology. Latest release May 8, 2026: Blau Farmacêutica: 33% revenue growth and margin expansion in 1Q26, with zero…
- Ticker
- B3:BLAU3
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- B3
- Currency
- BRL
About Blau Farmaceutica Sa
The company focuses on the pharmaceutical sector, offering a range of products and services. As a publicly traded entity, Blau Farmaceutica Sa is subject to regulatory oversight and provides transparency to its investors.
Latest news from Blau Farmaceutica Sa
Blau Farmacêutica: 33% revenue growth and margin expansion in 1Q26, with zero leverage and strong cash position
May 8, 2026
Blau Farmacêutica: Biosimilars and mAbs drive transformational growth, supported by expansion and innovation
April 7, 2026
Blau Farmacêutica: Record biotech investment and margin gains offset revenue dip; outlook for 2026 is strong
March 18, 2026
Blau Farmacêutica: Net income jumped 52% on stable revenue, margin gains, and divestment proceeds
November 4, 2025
Blau Farmacêutica: Gross margin and EBITDA hit record levels as capacity expansion and pipeline drive future growth
August 6, 2025
Research Blau Farmaceutica Sa
Blau Farmaceutica Sa company profile
View the public company page for Blau Farmaceutica Sa on 6ix.
Blau Farmaceutica Sa news
Read company news and market updates connected to Blau Farmaceutica Sa.
Blau Farmaceutica Sa investor events
Find investor webinars, events, and replay context for Blau Farmaceutica Sa.